Alvotech (ALVO) Selling, General & Administrative (2021 - 2026)
Powered by 
Analysis
Alvotech (ALVO) Selling, General & Administrative (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.72 Bn | 39.07 Bn | 2.15 Bn | 317.00 Mn |
| 2 | Viatris | 19.18 Bn | 18.29 Bn | 1.46 Bn | 1.13 Bn |
| 3 | Dr Reddys Laboratories | 9.89 Bn | 9.72 Bn | 396.53 Mn | 304.42 Mn |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.34 Bn | 334.51 Mn | 148.72 Mn |
| 5 | Bausch Health Companies | 2.34 Bn | 498.25 Mn | 2.10 Bn | 907.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -43.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | 91.66 Mn |
| 8 | Amphastar Pharmaceuticals | 995.30 Mn | 705.18 Mn | 93.47 Mn | 18.24 Mn |
| 9 | Fennec Pharmaceuticals | 397.96 Mn | 356.71 Mn | 17.15 Mn | 4.64 Mn |
| 10 | RedHill Biopharma | 179.11 Mn | 179.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -43.56 Mn |
| Mar 31, 2026 | -25.67 Mn |
| Dec 31, 2025 | -45.35 Mn |
| Sep 30, 2025 | -25.92 Mn |
| Jun 30, 2025 | -26.74 Mn |
| Mar 31, 2025 | -18.61 Mn |
| Dec 31, 2024 | -65.71 Mn |
| Sep 30, 2024 | -16.88 Mn |
| Jun 30, 2024 | -14.07 Mn |
| Mar 31, 2024 | -15.49 Mn |
| Dec 31, 2023 | -76.56 Mn |
| Aug 31, 2023 | -41.91 Mn |
| Jun 30, 2023 | -19.71 Mn |
| Mar 20, 2023 | -76.56 Mn |
| Dec 31, 2022 | -186.74 Mn |
| Aug 31, 2022 | -139.15 Mn |
| Jun 30, 2022 | 325.89 Mn |
| Mar 20, 2022 | -186.74 Mn |
| Dec 31, 2021 | -84.13 Mn |
| Sep 30, 2021 | -19.94 Mn |